mTOR is a Promising Therapeutic Target Both in Cisplatin-Sensitive and Cisplatin-Resistant Clear Cell Carcinoma of the Ovary

Por Mabuchi, Seiji, Kawase, Chiaki, Altomare, Deborah A., Morishige, Kenichirou, Sawada, Kenjiro, Hayashi, Masami, Tsujimoto, Masahiko, Yamoto, Mareo, Klein-Szanto, Andres J., Schilder, Russell J., Ohmichi, Masahide, Testa, Joseph R., Kimura, Tadashi
Publicado em 2009

VEGF is a Promising Therapeutic Target for the Treatment of Clear Cell Carcinoma of the Ovary

Por Mabuchi, Seiji, Kawase, Chiaki, Altomare, Deborah A., Morishige, Kenichirou, Hayashi, Masami, Sawada, Kenjiro, Ito, Kimihiko, Terai, Yoshito, Nishio, Yukihiro, Klein-Szanto, Andres J., Burger, Robert A., Ohmichi, Masahide, Testa, Joseph R., Kimura, Tadashi
Publicado em 2010